A Disposable Tear Glucose Biosensor—Part 3: Assessment of Enzymatic Specificity

Background: A concept for a tear glucose sensor based on amperometric measurement of enzymatic oxidation of glucose was previously presented, using glucose dehydrogenase flavin adenine dinucleotide (GDH-FAD) as the enzyme. Glucose dehydrogenase flavin adenine dinucleotide is further characterized in this article and evaluated for suitability in glucose-sensing applications in purified tear-like saline, with specific attention to the effect of interfering substances only. These interferents are specifically saccharides that could interact with the enzymatic activity seen in the sensor's performance. Methods: Bench top amperometric glucose assays were performed using an assay solution of GDH-FAD and ferricyanide redox mediator with samples of glucose, mannose, lactose, maltose, galactose, fructose, sucrose, and xylose at varying concentrations to evaluate specificity, linear dynamic range, signal size, and signal-to-noise ratio. A comparison study was done by substituting an equivalent activity unit concentration of glucose oxidase (GOx) for GDH-FAD. Results: Glucose dehydrogenase flavin adenine dinucleotide was found to be more sensitive than GOx, producing larger oxidation currents than GOx on an identical glucose concentration gradient, and GDH-FAD exhibited larger slope response (-5.65 × 10−7 versus −3.11 × 10−7 A/mM), signal-to-noise ratio (18.04 versus 2.62), and linear dynamic range (0–30 versus 0–10 mM), and lower background signal (−7.12 versus −261.63 nA) than GOx under the same assay conditions. GDH-FAD responds equally to glucose and xylose but is otherwise specific for glucose. Conclusion: Glucose dehydrogenase flavin adenine dinucleotide compares favorably with GOx in many sensor-relevant attributes and may enable measurement of glucose concentrations both higher and lower than those measurable by GOx. GDH-FAD is a viable enzyme to use in the proposed amperometric tear glucose sensor system and perhaps also in detecting extreme hypoglycemia or hyperglycemia in blood.

[1]  Kenji Kano,et al.  Novel FAD-Dependent Glucose Dehydrogenase for a Dioxygen-Insensitive Glucose Biosensor , 2006, Bioscience, biotechnology, and biochemistry.

[2]  Lewis S. Nelson,et al.  Unrecognized hypoglycemia due to maltodextrin interference with bedside glucometry , 2009, Journal of Medical Toxicology.

[3]  Justin T. Baca,et al.  Tear glucose analysis for the noninvasive detection and monitoring of diabetes mellitus. , 2007, The ocular surface.

[4]  Dorte Vistisen,et al.  Global healthcare expenditure on diabetes for 2010 and 2030. , 2010, Diabetes research and clinical practice.

[5]  Robin Felder,et al.  Flexible Rolled Thick‐Film Miniaturized Flow‐Cell for Minimally Invasive Amperometric Sensing , 2008 .

[6]  A Disposable Tear Glucose Biosensor—Part 1: Design and Concept Testing , 2010, Journal of diabetes science and technology.

[7]  A Heller,et al.  Cross-linked redox gels containing glucose oxidase for amperometric biosensor applications. , 1990, Analytical chemistry.

[8]  Hiroyuki Kudo,et al.  Soft contact lens biosensor for in situ monitoring of tear glucose as non-invasive blood sugar assessment. , 2011, Talanta.

[9]  Dharmendra R. Patel,et al.  A Disposable Tear Glucose Biosensor—Part 2: System Integration and Model Validation , 2010, Journal of diabetes science and technology.

[10]  B. Ginsberg.  Factors Affecting Blood Glucose Monitoring: Sources of Errors in Measurement , 2009, Journal of diabetes science and technology.

[11]  A. Turner,et al.  Ferrocene-mediated enzyme electrode for amperometric determination of glucose. , 1984, Analytical chemistry.

[12]  Justin T. Baca,et al.  Mass spectral determination of fasting tear glucose concentrations in nondiabetic volunteers. , 2007, Clinical chemistry.

[13]  A Heller,et al.  Design and optimization of a selective subcutaneously implantable glucose electrode based on "wired" glucose oxidase. , 1995, Analytical chemistry.